TRIMEPHAR
ActiveSummary
TRIMEPHAR has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €777,347 and a net result of €166,856. Equity remains stable across the filed financial years (±1.6% per year). Its solvency ranks better than 73% of 12,650 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
17-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
28-05
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
25-07
NBB filing
Annual accounts filed
financial year 2023 · full format
24-01
Gazette deed
Reappointment: PHARMACIE LEJEUNE (director)Permanent representative: OLIVIER François-Xavier Willy Ghislain · Purpose change · Amendment of the articles16 facts ▸
Gazette deed
Reappointment: PHARMACIE LEJEUNE (director)
Permanent representative: OLIVIER François-Xavier Willy Ghislain · Purpose change · Amendment of the articles16 facts ▸
- General meeting, 19-12-2023
- Other provision, “rapport organe d'administration justifiant modification objet, prend acte,non annexé au procès-verbal,déposé en original au greffe du tribunal de l'entreprise a…” (deed in French)
- Purpose change
- Other provision, “mise en concordance statuts avec résolution objet, reporter établissement définitif texte modifications consécutives dans cadre résolution point III(refonte)” (deed in French)
- Other provision, “mise en concordance statuts avec résolution assemblée générale ordinaire, reporter établissement définitif texte modifications consécutives dans cadre résolutio…” (deed in French)
- Other provision, “refonte statuts pour homogénéité avec statuts autres sociétés similaires détenues par actionnaire unique, refondre” (deed in French)
- Amendment of the articles
- Capital
- Other provision, “Article 6 Appels de fonds” (deed in French)
- Other provision, “Article 8 Apport en numéraire avec émission de nouvelles actions – Droit de préférence” (deed in French)
- Director reappointment, PHARMACIE LEJEUNE (director (not named in the articles))
- Other provision, “administrateur, représentation pour désignation du représentant permanent” (deed in French) (2 times)
- +4 further facts in this act
2023
31-07
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
30-06
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
30-07
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
10-09
NBB filing
Annual accounts filed
financial year 2019 · full format · 41 days late
2019
31-12
Financial
Equity above €1mequity €1.1m ▲22.6%
A profit in every financial year since 2018 builds equity to €1.1m.
22-10
NBB filing
Annual accounts filed
financial year 2018 · full format · 83 days late
2018
24-10
NBB filing
Annual accounts filed
financial year 2017 · full format · 85 days late
2017
29-09
NBB filing
Annual accounts filed
financial year 2016 · full format · 60 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 17 annual accounts filed, the latest 10 are here; all 17 are under Financials.
1 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.